Message From the Editor-in-Chief
Message From the Editor-in-Chief
2017 Volume 81 Issue 9 Pages 1241-1245
Details
2017 Volume 81 Issue 9 Pages 1241-1245
Dear Colleagues,
On behalf of the Circulation Journal, I am pleased to report the most frequently quoted CJ papers in 2016 by category that substantially contributed to the 2016 impact factor of the Journal.
The Most Frequently Quoted CJ Papers (2014–2015) in 2016 by CategoryThe following papers, published in 2014–2015, were among the most frequently quoted papers in 2016 by category, thereby substantially contributing to the 2016 Impact Factor of the Journal (number in the parenthesis denotes the number of quotation in 2014–2015).
1. Arrhythmia/Electrophysiology1. (14) Akao M, Chun YH, Esato M, Abe M, Tsuji H, Wada H, et al; on behalf of the Fushimi AF Registry Investigators. Inappropriate use of oral anticoagulants for patients with atrial fibrillation: 1-year outcomes of the Fushimi AF Registry. Circ J 2014; 78: 2166–2172.
2. (13) Okumura K, Inoue H, Atarashi H, Yamashita T, Tomita H, Origasa H; for the J-RHYTHM Registry Investigators. Validation of CHA2DS2-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: An analysis of the J-RHYTHM Registry. Circ J 2014; 78: 1593–1599.
3. (10) Okamura H, Kamakura T, Morita H, Tokioka K, Nakajima I, Wada M, et al. Risk stratification in patients with Brugada syndrome without previous cardiac arrest: Prognostic value of combined risk factors. Circ J 2015; 79: 310–317.
4. (8) Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, et al; on behalf of the J-ROCKET AF Study Investigators. Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age: Insight from J-ROCKET AF. Circ J 2014; 78: 1349–1356.
(8) Inoue K, Murakawa Y, Nogami A, Shoda M, Naito S, Kumagai K, et al; on behalf of the Japanese Heart Rhythm Society Members. Current status of catheter ablation for atrial fibrillation: Updated summary of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF). Circ J 2014; 78: 1112–1120.
(8) Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H; on behalf of the J-RHYTHM Registry Investigators. Use of warfarin in elderly patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry. Circ J 2015; 79: 2345–2352.
2. Cardiovascular Intervention1. (10) Kubo T, Akasaka T, Kozuma K, Kimura K, Fusazaki T, Okura H, et al; on behalf of the NEXT Investigators. Vascular response to drug-eluting stent with biodegradable vs. durable polymer: Optical coherence tomography substudy of the NEXT. Circ J 2014; 78: 2408–2414.
2. (9) Kobayashi Y, Okura H, Kume T, Yamada R, Kobayashi Y, Fukuhara K, et al. Impact of target lesion coronary calcification on stent expansion: An optical coherence tomography study. Circ J 2014; 78: 2209–2214.
3. (8) Yabushita H, Takagi K, Tahara S, Fujino Y, Warisawa T, Kawamoto H, et al. Impact of rotational atherectomy on heavily calcified, unprotected left main disease: The new Tokyo Registry. Circ J 2014; 78: 1867–1872.
(8) Shiono Y, Kubo T, Tanaka A, Ino Y, Yamaguchi T, Tanimoto T, et al. Long-term outcome after deferral of revascularization in patients with intermediate coronary stenosis and gray-zone fractional flow reserve. Circ J 2015; 79: 91–95.
5. (7) Maeda K, Kuratani T, Torikai K, Mizote I, Ichibori Y, Onishi T, et al. New self-expanding transcatheter aortic valve device for transfemoral implantation: Early results of the first-in-Asia implantation of the ACURATE Neo/TFTM system. Circ J 2015; 79: 1037–1043.
(7) Fujihara M, Yokoi Y, Abe T, Soga Y, Yamashita T, Miyashita Y, et al; on behalf of the J-RAS Study Investigators. Clinical outcome of renal artery atenting for hypertension and chronic kidney disease up to 12 months in the J-RAS Study: Prospective, single-arm, multicenter clinical study. Circ J 2015; 79: 351–359.
3. Cardiovascular Surgery1. (8) Imamura T, Kinugawa K, Kato N, Muraoka H, Fujino T, Inaba T, et al. Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J 2014; 78: 625–633.
(8) Ohira S, Doi K, Numata S, Yamazaki S, Yamamoto T, Fukuishi M, et al. Does age at operation influence the short- and long-term outcomes of off-pump coronaryartery bypass grafting? Circ J 2015; 79: 2177–2185.
3. (7) Imamura T, Kinugawa K, Fujino T, Inaba T, Maki H, Hatano M, et al. Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation. Circ J 2015; 79: 104–111.
4. (6) Tokuda Y, Miyata H, Motomura N, Oshima H, Usui A, Takamoto S; Japan Adult Cardiovascular Database Organization. Brain protection during ascending aortic repair for Stanford type A acute aortic dissection surgery: Nationwide analysis in Japan. Circ J 2014; 78: 2431–2438.
(6) Nishida T, Sonoda H, Oishi Y, Tatewaki H, Tanoue Y, Shiokawa Y, et al. Long-term results of aortic valve replacement with mechanical prosthesis or Carpentier-Edwards Perimount bioprosthesis in Japanese patients according to age. Circ J 2014; 78: 2688–2695.
4. Heart Failure1. (13) Enomoto M, Ishizu T, Seo Y, Yamamoto M, Suzuki H, Shimano H, et al. Subendocardial systolic dysfunction in asymptomatic normotensive diabetic patients. Circ J 2015; 79: 1749–1755.
2. (11) Shirakabe A, Hata N, Yamamoto M, Kobayashi N, Shinada T, Tomita K, et al. Immediate administration of tolvaptan prevents the exacerbation of acute kidney injury and improves the mid-term prognosis of patients with severely decompensated acute heart failure. Circ J 2014; 78: 911–921.
3. (10) Ushigome R, Sakata Y, Nochioka K, Miyata S, Miura M, Tadaki S, et al; on behalf of the CHART-2 Investigators. Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in Japan: Report from the CHART Studies. Circ J 2015; 79: 2396–2407.
4. (9) Imamura T, Kinugawa K, Hatano M, Fujino T, Inaba T, Maki H, et al. Low cardiac output stimulates vasopressin release in patients with stage D heart failure: Its relevance to poor prognosis and reversal by surgical treatment. Circ J 2014; 78: 2259–2267.
(9) Imamura T, Kinugawa K, Fujino T, Inaba T, Maki H, Hatano M, et al. Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure. Circ J 2014; 78: 2240–2249.
5. Imaging1. (9) Hen Y, Iguchi N, Utanohara Y, Takada K, Machida H, Takayama M, et al. Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging in Japanese hypertrophic cardiomyopathy patients. Circ J 2014; 78: 929–937.
(9) Nishiyama Y, Miyagawa M, Kawaguchi N, Nakamura M, Kido T, Kurata A, et al. Combined supine and prone myocardial perfusion single-photon emission computed tomography with a cadmium zinc telluride camera for detection of coronary artery disease. Circ J 2014; 78: 1169–1175.
3. (7) Maruo T, Seo Y, Yamada S, Arita T, Ishizu T, Shiga T, et al. The speckle tracking imaging for the assessment of cardiac resynchronization therapy (START) Study. Circ J 2015; 79: 613–622.
4. (6) Tanaka H, Chikamori T, Tanaka N, Hida S, Igarashi Y, Yamashita J, et al. Diagnostic performance of a novel cadmium-zinc-telluride gamma camera system assessed using fractional flow reserve. Circ J 2014; 78: 2727–2734.
(6) Nishimiya K, Matsumoto Y, Uzuka H, Oyama K, Tanaka A, Taruya A, et al. Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans: A validation study. Circ J 2015; 79: 1323–1331.
6. Ischemic Heart Disease1. (14) Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, et al. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study. Circ J 2014; 78: 1684–1692.
2. (11) Campos CM, van Klaveren D, Iqbal J, Onuma Y, Zhang YJ, Garcia-Garcia HM, et al. Predictive performance of SYNTAX score II in patients with left main and multivessel coronary artery disease: Analysis of CREDO-Kyoto Registry. Circ J 2014; 78: 1942–1949.
3. (8) Goto S, Huang CH, Park SJ, Emanuelsson H, Kimura T. Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome: Randomized, double-blind, phase III PHILO Study. Circ J 2015; 79: 2452–2460.
4. (7) Emoto T, Sasaki N, Yamashita T, Kasahara K, Yodoi K, Sasaki Y, et al. Regulatory/effector T-cell ratio is reduced in coronary artery disease. Circ J 2014; 78: 2935–2941.
(7) Nishimiya K, Matsumoto Y, Shindo T, Hanawa K, Hasebe Y, Tsuburaya R, et al. Association of adventitial vasa vasorum and inflammation with coronary hyperconstriction after drug-eluting stent implantation in pigs in vivo. Circ J 2015; 79: 1787–1798.
(7) Fujii T, Suzuki T, Torii S, Murakami T, Nakano M, Nakazawa G, et al. Diagnostic accuracy of Global Registry of Acute Coronary Events (GRACE) risk score in ST-elevation myocardial infarction for in-hospital and 360-day mortality in Japanese patients. Circ J 2014; 78: 2950–2954.
(7) Kim BJ, Kim BS, Kang JH. Echocardiographic epicardial fat thickness is associated with coronary artery calcification: Results from the CAESAR study. Circ J 2015; 79: 818–824.
7. Molecular Cardiology/Myocardial Disease1. (10) Gómez J, Reguero JR, Morís C, Martín M, Alvarez V, Alonso B, et al. Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing. Circ J 2014; 78: 2963–2971. (Molecular Cardiology)
2. (7) Kawaji T, Shiomi H, Morimoto T, Tazaki J, Imai M, Saito N, et al. Clinical impact of left ventricular outflow tract obstruction in takotsubo cardiomyopathy. Circ J 2015; 79: 839–846. (Myocardial Disease)
(7) Nagai T, Nagano N, Sugano Y, Asaumi Y, Aiba T, Kanzaki H, et al. Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis. Circ J 2015; 79: 1593–1600. (Myocardial Disease)
(7) Jung YS, Lee JS, Min YG, Park JS, Jeon WC, Park EJ, et al. Carbon monoxide-induced cardiomyopathy: Epidemiology, clinical characteristics and prognosis. Circ J 2014; 78: 1437–1444. (Myocardial Disease)
5. (6) Shimizu M, Nishizaki M, Yamawake N, Fujii H, Sakurada H, Isobe M, et al. J wave and fragmented QRS formation during the hyperacute phase in takotsubo cardiomyopathy: Possible markers for severity of myocardial damage. Circ J 2014; 78: 943–949. (Myocardial Disease)
8. Pediatric Cardiology and Adult Congenital Heart Disease1. (6) Hashimoto I, Watanabe K. Alternation of right ventricular contraction pattern in healthy children: Shift from radial to longitudinal direction at approximately 15 mm of tricuspid annular plane systolic excursion. Circ J 2014; 78: 1967–1973.
2. (5) Trigas V, Nagdyman N, Pildner von Steinburg S, Oechslin E, Vogt M, Berger F, et al. Pregnancy-related obstetric and cardiologic problems in women after atrial switch operation for transposition of the great arteries. Circ J 2014; 78: 443–449.
(5) Lu CW, Shih JC, Chen SY, Chiu HH, Wang JK, Chen CA, et al. Comparison of 3 risk estimation methods for predicting cardiac outcomes in pregnant women with congenital heart disease. Circ J 2015; 79: 1609–1617.
(5) Chien SJ, Lin IC, Hsu CN, Lo MH, Tain YL. Homocysteine and arginine-to-asymmetric dimethylarginine ratio associated with blood pressure abnormalities in children with early chronic kidney disease. Circ J 2015; 79: 2031–2037.
9. Peripheral Vascular Disease/Pulmonary Circulation1. (9) Elias-Al-Mamun M, Satoh K, Tanaka S, Shimizu T, Nergui S, Miyata S, et al. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats. Circ J 2014; 78: 967–976. (Pulmonary Circulation)
2. (8) Urushibara T, Tanabe N, Suda R, Kato F, Kasai H, Takeuchi T, et al. Effects of surgical and medical treatment on quality of life for patients with chronic thromboembolic pulmonary hypertension. Circ J 2015; 79: 2696–2702. (Pulmonary Circulation)
3. (6) Tanaka H, Katsuragi S, Osato K, Hasegawa J, Nakata M, Murakoshi T, et al. Increase in maternal death-related venous thromboembolism during pregnancy in Japan (2010–2013). Circ J 2015; 79: 1357–1362. (Peripheral Vascular Disease)
(6) Kajikawa M, Maruhashi T, Iwamoto Y, Iwamoto A, Matsumoto T, Hidaka T, et al. Borderline ankle-brachial index value of 0.91–0.99 is associated with endothelial dysfunction. Circ J 2014; 78: 1740–1745. (Peripheral Vascular Disease)
5. (5) Yamaki S, Ando M, Fukumoto Y, Higuchi Y, Kaneko K, Maeda K, et al. Histopathological examination by lung biopsy for the evaluation of operability and postoperative prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2014; 78: 476–482. (Pulmonary Circulation)
10. Reviews/Editorials1. (22) Scantlebury DC, Prasad A. Diagnosis of takotsubo cardiomyopathy: Mayo clinic criteria. Circ J 2014; 78: 2129–2139. (Review)
2. (16) De Paoli F, Staels B, Chinetti-Gbaguidi G. Macrophage phenotypes and their modulation in atherosclerosis. Circ J 2014; 78: 1775–1781. (Review)
(16) Sharkey SW, Maron BJ. Epidemiology and clinical profile of takotsubo cardiomyopathy. Circ J 2014; 78: 2119–2128. (Review)
4. (15) Yatsuya H, Li Y, Hilawe EH, Ota A, Wang C, Chiang C, et al. Global trend in overweight and obesity and its association with cardiovascular disease incidence. Circ J 2014; 78: 2807–2818. (Review)
(15) Mizusawa Y, Horie M, Wilde AAM. Genetic and clinical advances in congenital long QT syndrome. Circ J 2014; 78: 2827–2833. (Review)
6. (14) De Rosa S, Curcio A, Indolfi C. Emerging role of microRNAs in cardiovascular diseases. Circ J 2014; 78: 567–575. (Review)
(14) Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 2015; 79: 495–502. (Review)
8. (12) Towbin JA. Inherited cardiomyopathies. Circ J 2014; 78: 2347–2356. (Review)
9. (11) Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, et al. Production of reactive oxygen species in the diabetic heart: Roles of mitochondria and NADPH oxidase. Circ J 2014; 78: 300–306. (Review)
(11) Kurisu S, Kihara Y. Clinical management of takotsubo cardiomyopathy. Circ J 2014; 78: 1559–1566. (Review)
11. (10) Miyagawa M, Yokoyama R, Nishiyama Y, Ogimoto A, Higaki J, Mochizuki T. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases: Sarcoidosis, large-vessel arteritis, and atherosclerosis. Circ J 2014; 78: 1302–1310. (Review)
(10) Alfonso F, Bastante T, Rivero F, Cuesta J, Benedicto A, Saw J, et al. Spontaneous coronary artery dissection: From diagnosis to management. Circ J 2014; 78: 2099–2110. (Review)
13. (9) Bulluck H, Maestrini V, Rosmini S, Abdel-Gadir A, Treibel TA, Castelletti S, et al. Myocardial T1 mapping: Hope or hype? Circ J 2015; 79: 487–494. (Review)
(9) Tara S, Rocco KA, Hibino N, Sugiura T, Kurobe H, Breuer CK, et al. Vessel bioengineering: Development of small-diameter arterial grafts. Circ J 2014; 78: 12–19. (Review)
(9) Komajda M. Current challenges in the management of heart failure. Circ J 2015; 79: 948–953. (Review)
11. LBCT/LBCS/Rapid1. (15) Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, et al; of the SYMPLICITY HTN-Japan Investigators. SYMPLICITY HTN-Japan: First randomized controlled trial of catheter-based renal denervation in Asian patients. Circ J 2015; 79: 1222–1229. (LBCT)
(15) Momomura S, Seino Y, Kihara Y, Adachi H, Yasumura Y, Yokoyama H, et al; for the SAVIOR-C investigators. Adaptive servo-ventilation therapy for patients with chronic heart failure in a confirmatory, multicenter, randomized, controlled study. Circ J 2015; 79: 981–990. (LBCT)
(15) Ishihara M, Fujino M, Ogawa H, Yasuda S, Noguchi T, Nakao K, et al; on behalf of the J-MINUET investigators. Clinical presentation, management and outcome of Japanese patients with acute myocardial infarction in the troponin era: Japanese registry of acute myocardial infarction diagnosed by universal definition (J-MINUET). Circ J 2015; 79: 1255–1262. (LBCS)
4. (14) Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K. Efficacy and safety of tolvaptan in heart failure patients with volume overload: An interim result of post-marketing surveillance in Japan. Circ J 2014; 78: 844–852. (LBCS)
5. (13) Hirayama A, Honarpour N, Yoshida M, Yamashita S, Huang F, Wasserman SM, et al. Effects of evolocumab (AMG 145), a monoclonal antibody to PCSK9, in hypercholesterolemic, statin-treated Japanese patients at high cardiovascular risk: Primary results from the phase 2 YUKAWA study. Circ J 2014; 78: 1073–1082. (LBCT)
6. (5) Murakawa Y, Nogami A, Shoda M, Inoue K, Naito S, Kumagai K, et al; on behalf of the Japanese Heart Rhythm Society Members. Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF): Report of 1-year follow-up. Circ J 2014; 78: 1091–1096. (LBCS)
(5) Sawa Y, Yoshikawa Y, Toda K, Fukushima S, Yamazaki K, Ono M, et al. Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease. Circ J 2015; 79: 991–999. (LBCT)
(5) Sasaki S, Tomita H, Shibutani S, Izumiyama K, Higuma T, Itoh T, et al. Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death: A single-center primary experience. Circ J 2014; 78: 2987–2989. (Rapid)
9. (4) Sawa Y, Saito S, Kobayashi J, Niinami H, Kuratani T, Maeda K, et al; for the MDT-2111 Japan Investigators. First clinical trial of a self-expandable transcatheter heart valve in Japan in patients with symptomatic severe aortic stenosis. Circ J 2014; 78: 1083–1090. (LBCT)
(4) Suzuki H, Matsumoto Y, Kaneta T, Sugimura K, Takahashi J, Fukumoto Y, et al. Evidence for brain activation in patients with takotsubo cardiomyopathy. Circ J 2014; 78: 256–258. (Rapid)
(4) Nakamura M, Nishikawa M, Komuro I, Kitajima I, Uetsuka Y, Yamagami T, et al. Apixaban for the treatment of Japanese subjects with acute venous thromboembolism (AMPLIFY-J Study). Circ J 2015; 79: 1230–1236. (LBCT)
12. Other Categories1. (40) JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013): Digest version. Circ J 2014; 78: 1997–2021. (Guideline)
2. (19) JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013): Digest version. Circ J 2014; 78: 2779–2801. (Guideline)
3. (11) Yoshihara T, Shimada K, Fukao K, Sai E, Sato-Okabayashi Y, Matsumori R, et al. Omega 3 polyunsaturated fatty acids suppress the development of aortic aneurysms through the inhibition of macrophage-mediated inflammation. Circ J 2015; 79: 1470–1478. (Aortic Disease)
4. (10) JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013): Digest version. Circ J 2014; 78: 2521–2562. (Guideline)
5. (7) Takata K, Imaizumi S, Kawachi E, Suematsu Y, Shimizu T, Abe S, et al. Impact of cigarette smoking cessation on high-density lipoprotein functionality: VN-SEESAW-HDL. Circ J 2014; 78: 2955–2962. (Metabolic Disorder)
(7) Hori A, Nanri A, Sakamoto N, Kuwahara K, Nagahama S, Kato N, et al; for the Japan Epidemiology Collaboration on Occupational Health Study Group. Comparison of body mass index, waist circumference, and waist-to-height ratio for predicting the clustering of cardiometabolic risk factors by age in Japanese workers: Japan epidemiology collaboration on occupational health study. Circ J 2014; 78: 1160–1168. (Epidemiology)
(7) Yoshimuta T, Yokoyama H, Okajima T, Tanaka H, Toyoda K, Nagatsuka K, et al. Impact of elevated D-Dimer on diagnosis of acute aortic dissection with isolated neurological symptoms in ischemic stroke. Circ J 2015; 79: 1841–1845. (Stroke)
The Editorial Team looks forward to receiving manuscripts with high scientific impact from all over the world.
